Skip to main content

Option Care Health Value Stock - Dividend - Research Selection

Bioscrip

ISIN: US68404L2016 , WKN: A2PZEY

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient\'s homes, outpatient clinics, nursing facilities, physician\'s offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Best Growth Stocks to Buy for September 15th

2023-09-15
FOUR, OPCH and JOB made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 15, 2023.

First Week of January 2026 Options Trading For Option Care Health (OPCH)

2023-09-13
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Best Growth Stocks to Buy for September 12th

2023-09-12
OPCH, NJDCY and AMWD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 12, 2023.

Tracking Dan Loeb's Third Point Portfolio - Q2 2023 Update

2023-09-12
Dan Loeb's 13F portfolio value increased from $6.11B to $6.82B this quarter. Click here to read the portfolio's full Q2 2023 update.

Grocery, Medical Tenants Lease 3 Storefronts at Ditmas Park Development

2023-09-08
Delight Bazar Supermarket, Option Care Health and Quest Diagnostics are moving to 1041 Coney Island Avenue, a new six-story mixed-use building in Ditmas Park, Brooklyn, according to brokers on the deal. All three tenants signed 10-year leases for space on the ground floor, said MOD Commercial Realty’s Meyer Dagmy, who represented the building’s owner, Foster and Coney Realty. Delight Bazar signed on for 6,500 square feet, taking the largest ground-floor retail unit in the building.

Zacks Industry Outlook Highlights DaVita, Encompass Health, Option Care Health and RadNet

2023-09-05
DaVita, Encompass Health, Option Care Health and RadNet are part of the Zacks Industry Outlook article.

Here's Why We Think Option Care Health (NASDAQ:OPCH) Is Well Worth Watching

2023-09-04
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

4 Stocks to Buy in a Booming Outpatient Home Health Industry

2023-09-01
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and RDNT are well-poised to gain.

Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q2 2023 Update

2023-08-31
Duquesne Family Office's Q2 2023 13F portfolio value surged 25% to $2.87B, with top holdings in Nvidia, Coupang, Microsoft, Eli Lilly, and Lamb Weston.

Option Care Health to Participate in Upcoming Investor Conference

2023-08-31
BANNOCKBURN, Ill., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the Morgan Stanley 21st Annual Global Healthcare Conference, being held in New York, on Tuesday, September 12, 2023, including a fireside chat at 2:55pm ET. About Option Care Health Option Care Health is the nation’s largest independent provider of home and alternate